We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$3.87B
AUM Growth
+$9.15M
Cap. Flow
-$43.3M
Cap. Flow %
-1.12%
Top 10 Hldgs %
66.62%
Holding
371
New
17
Increased
68
Reduced
106
Closed
6

Top Buys

Rank Stock Value
1
IAI icon
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
+$90.5M
2
GS icon
Goldman Sachs
GS
+$39.1M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$38.1M
4
NKE icon
Nike
NKE
+$7.43M
5
MDT icon
Medtronic
MDT
+$7.07M

Top Sells

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$117M
2
JNJ icon
Johnson & Johnson
JNJ
+$30.9M
3
NVDA icon
NVIDIA
NVDA
+$17.4M
4
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$14.5M
5
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 5.21%
2 Healthcare 4.04%
3 Financials 3.05%
4 Consumer Discretionary 3.02%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDW icon
251
CDW
CDW
$16.6B
$224 ﹤0.01%
1
– –
HOLX
252
DELISTED
Hologic
HOLX
$223 ﹤0.01%
3
-1
-25% -$75
STE icon
253
Steris
STE
$20.9B
$220 ﹤0.01%
1
-1
-50% -$217
DLTR icon
254
Dollar Tree
DLTR
$24.3B
$214 ﹤0.01%
2
– –
EL icon
255
Estee Lauder
EL
$30.3B
$213 ﹤0.01%
2
– –
MET icon
256
MetLife
MET
$59.8B
$211 ﹤0.01%
3
+1
+50% +$71
RVTY icon
257
Revvity
RVTY
$11.9B
$210 ﹤0.01%
2
– –
TFX icon
258
Teleflex
TFX
$5.93B
$210 ﹤0.01%
1
– –
CHD icon
259
Church & Dwight Co
CHD
$23.2B
$207 ﹤0.01%
2
– –
CRL icon
260
Charles River Laboratories
CRL
$10.6B
$207 ﹤0.01%
1
– –
CTSH icon
261
Cognizant
CTSH
$21.1B
$204 ﹤0.01%
3
– –
LH icon
262
Labcorp
LH
$23.1B
$204 ﹤0.01%
1
– –
LNT icon
263
Alliant Energy
LNT
$19.1B
$204 ﹤0.01%
4
– –
TRV icon
264
Travelers Companies
TRV
$78.4B
$203 ﹤0.01%
1
– –
ACGL icon
265
Arch Capital
ACGL
$35.6B
$202 ﹤0.01%
2
+1
+100% +$97
NI icon
266
NiSource
NI
$21.8B
$202 ﹤0.01%
7
+1
+17% +$28
PODD icon
267
Insulet
PODD
$11.6B
$202 ﹤0.01%
1
– –
BAX icon
268
Baxter International
BAX
$11.4B
$201 ﹤0.01%
6
-2
-25% -$74
HIG icon
269
Hartford Financial Services
HIG
$38.5B
$201 ﹤0.01%
2
+1
+100% +$100
MKTX icon
270
MarketAxess Holdings
MKTX
$4.08B
$201 ﹤0.01%
+1
New +$206
LYV icon
271
Live Nation Entertainment
LYV
$42.1B
$187 ﹤0.01%
2
– –
UHS icon
272
Universal Health Services
UHS
$9.12B
$185 ﹤0.01%
1
– –
HSY icon
273
Hershey
HSY
$34.8B
$184 ﹤0.01%
1
– –
PTC icon
274
PTC
PTC
$14.4B
$182 ﹤0.01%
1
– –
OMC icon
275
Omnicom Group
OMC
$23.5B
$179 ﹤0.01%
2
– –
9 10
11
12 13

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $4.12B AUM
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return

WestEnd Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, WestEnd Advisors held 371 positions worth $3.87B, up 0.24% from $3.86B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

WestEnd Advisors's Q2 2024 filing shows 17 new, 68 increased, 106 reduced and 6 closed positions. Its largest new stake was iShares US Broker-Dealers & Securities Exchanges ETF: 785,417 shares worth $91.8M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $117M.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Financials.

  • WestEnd Advisors's largest Q2 2024 buy was iShares US Broker-Dealers & Securities Exchanges ETF: 785,417 shares worth $91.8M.
  • WestEnd Advisors added most to Goldman Sachs in Q2 2024, an estimated $39.1M increase.
  • WestEnd Advisors's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $117M.
  • WestEnd Advisors fully exited iShares MSCI France ETF in Q2 2024, selling an estimated $138K.
  • WestEnd Advisors's ten largest holdings make up 67% of its $3.87B portfolio in Q2 2024.
  • WestEnd Advisors opened 17 new positions and closed 6 in Q2 2024.
  • WestEnd Advisors's portfolio value rose 0.24% quarter-over-quarter to $3.87B.

Based on WestEnd Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.